Antengene (HKSE:06996) Price-to-Tangible-Book : 0.44 (As of Jun. 24, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Antengene Price-to-Tangible-Book?

As of today (2024-06-24), Antengene's share price is HK$0.81. Antengene's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was HK$1.85. Hence, Antengene's Price to Tangible Book Ratio of today is 0.44.

The historical rank and industry rank for Antengene's Price-to-Tangible-Book or its related term are showing as below:

HKSE:06996' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.43 Med: 2.04 Max: 3.2
Current: 0.44

During the past 6 years, Antengene's highest Price to Tangible Book Ratio was 3.20. The lowest was 0.43. And the median was 2.04.

HKSE:06996's Price-to-Tangible-Book is ranked better than
95.53% of 1209 companies
in the Biotechnology industry
Industry Median: 2.63 vs HKSE:06996: 0.44

A closely related ratio is called PB Ratio. As of today, Antengene's share price is HK$0.81. Antengene's Book Value per Sharefor the quarter that ended in Dec. 2023 was HK$1.86. Hence, Antengene's P/B Ratio of today is 0.44.

Antengene Price-to-Tangible-Book Historical Data

The historical data trend for Antengene's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antengene Price-to-Tangible-Book Chart

Antengene Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

3.20

2.25

1.82

1.08

Antengene Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial						2.25	1.85	1.82	0.66	1.08

Competitive Comparison of Antengene's Price-to-Tangible-Book

For the Biotechnology subindustry, Antengene's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Antengene's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Antengene's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Antengene's Price-to-Tangible-Book falls into.

Antengene Price-to-Tangible-Book Calculation

Antengene's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.81	/	1.854
	=	0.44

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Antengene Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Antengene's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Antengene (HKSE:06996) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Antengene Corp Ltd (HKSE:06996) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN

Website

https://www.antengene.com

Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically it operates in China and other regions.

Executives

Jay Mei 2023 Grat	2201 Interest of corporation controlled by you
Mei Jay	2201 Interest of corporation controlled by you
Begonia Investment Ltd.	2101 Beneficial owner
Qiming Corporate Gp V, Ltd.
The Core Trust Company Limited	2301 Trustee
Tct (bvi) Limited	2501 Other
Fountainvest China Capital Partners Gp3 Ltd.	2201 Interest of corporation controlled by you
Fountainvest China Capital Partners Fund Iii, L.p.	2201 Interest of corporation controlled by you
Fmr Llc	2201 Interest of corporation controlled by you
Fidelity Investment Trust	2101 Beneficial owner
Jay Mei 2020 Grat	2201 Interest of corporation controlled by you
Meiland Pharma Tech Spc
Boyu Capital Group Holdings Ltd	2201 Interest of corporation controlled by you
Boyu Capital General Partner Iii, Ltd
Boyu Capital General Partner Iii, L.p.

Antengene (HKSE:06996) Headlines

No Headlines